• Study of intranasal insulin to prevent delirium in patients aged 65 years or older following elective cardiac surgery

    Not recruiting

    4 1 1
    Investigated Drugs:
    The Netherlands

  • A study to evaluate the safety and effectiveness of AZD9750 and saruparib in patients with metastatic prostate cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands Spain

  • A study comparing the effectiveness of vorolanib and aflibercept in patients with diabetic macular edema

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Czechia Germany Hungary

  • A study to evaluate the efficacy and safety of vixarelimab in patients with moderate to severe ulcerative colitis

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia France Germany Greece Italy +1

  • Study of Tarlatamab and Durvalumab compared to Durvalumab alone for patients with extensive stage small cell lung cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Austria Belgium Bulgaria Czechia Denmark France +10

  • A Study to Evaluate the Safety and Effectiveness of Ritlecitinib Tosilate in Adults with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    2 1
    Germany Greece Poland Spain

  • Phase III Study of the Efficacy and Safety of Fenebrutinib Compared with Teriflunomide in Adult Patients with Relapsing Multiple Sclerosis

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Bulgaria Denmark France Greece Italy +1

  • A study to evaluate the safety and effectiveness of galvokimig in adults with moderate to severe atopic dermatitis

    Not recruiting

    2 1
    Investigated Diseases:
    Bulgaria Czechia Germany Hungary Poland

  • A study to compare how asundexian is absorbed in healthy adults using different formulations and the effect of food for the prevention of blood clots.

    Not recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany

  • A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)

    Not recruiting

    3 1
    Austria Belgium Bulgaria Czechia Denmark Estonia +16

powered by